Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis
Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis is a paper indexed in PICO Portal from OpenAlex.
How many citations does Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis have?
Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis has 170 citations in the OpenAlex counts PICO Portal stores.
When was Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis published?
Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis has 2009 year in the PICO Portal index.
What is the open-access status of Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis?
Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis has bronze oa status in the PICO Portal index.
What is the DOI of Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis?
The DOI for Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis is on the source record.
What is the PMID of Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis?
The PMID for Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis is on the source record.
What is the OpenAlex record for Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis?
The OpenAlex for Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis is on the source record.